Syros
$7.099876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.
$7.09
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
-$0.24 (-3.21%) As of 1:14 PM EST today
-$0.24 (-3.21%) Today
Why Robinhood?
You can buy or sell Syros and other stocks, options, ETFs, and crypto commission-free!
About SYRS
Syros Pharmaceuticals, Inc. engages in the development of novel gene control therapies for cancer and other diseases. It has developed a proprietary platform that is designed to systematically and efficiently analyse unexploited region of DNA in human disease tissue to identify and drug novel targets linked to genomically defined patient populations. Read More The firm focuses on developing treatments for cancer and immune mediated diseases and is building a pipeline of gene control medicines. The company was founded by Richard A. Young, Nathanael S. Gray and James E. Bradner on November 9, 2011 and is headquartered in Cambridge, MA.
Employees
76
Headquarters
Cambridge, Massachusetts
Founded
2011
Market Cap
334.01M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
160.29K
High Today
$7.31
Low Today
$7.05
Open Price
$7.31
Volume
77.68K
52 Week High
$11.93
52 Week Low
$4.45
Collections
Analyst Ratings
71%
of 7 ratings
Buy
71%
Hold
29%
Sell
0%
SYRS Earnings
-$0.57
-$0.38
-$0.19
$0.00
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Q3 2019
Q4 2019
Estimated
— per share
Actual
Expected Mar 5, Pre-Market
People Also Bought
Aurora Cannabis
671,453
$1.66
-1.19%Nokia
65,863
$4.16
+0.09%CymaBay Therapeutics
5,299
$1.79
0.00%Cyclerion Therapeutics
1,933
$4.84
-9.53%Hexo
166,629
$1.44
-0.35%Corbus Pharmaceuticals
49,068
$5.57
-1.76%Viking Therapeutics
38,948
$6.87
-1.36%CannTrust
103,244
$0.8233
-2.06%Party City
5,146
$2.98
+0.17%Inovio
55,820
$3.74
+2.71%Intelsat
12,684
$4.51
-0.66%SmileDirectClub
25,761